Comparison of Operation Time, Drain Duration, and Seroma Formation After Modified Radical Mastectomy Using Ultrasonic Dissector Versus Electrocautery in Women With Breast Cancer

NCT ID: NCT07050329

Last Updated: 2025-07-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

138 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-04

Study Completion Date

2024-12-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial was to compare two surgical techniques-ultrasonic dissector and electrocautery-for performing axillary dissection in women undergoing modified radical mastectomy (MRM) for breast cancer. The study aimed to determine whether using an ultrasonic dissector reduces operation time, the number of days surgical drains remain in place, and the frequency of seroma formation compared to conventional electrocautery.

The main questions the study aims to answer are:

1. Does the ultrasonic dissector reduce the duration of surgery compared to electrocautery?
2. Do patients operated with an ultrasonic dissector require surgical drains for fewer days?
3. Is the frequency of postoperative seroma formation lower in the ultrasonic dissector group?

Researchers randomly (1:1) assigned 138 women with breast cancer (aged 35-65 years) undergoing MRM to either the ultrasonic dissector group or the electrocautery group. All surgeries were performed by experienced consultant surgeons using standardized protocols.

Participants:

* Underwent MRM with either electrocautery or ultrasonic dissector for axillary dissection
* Were discharged 24 hours after surgery with two drains in place
* Measured and reported daily drain output at home
* Returned for weekly follow-up for 30 days postoperatively

Outcomes were measured by recording the operation time, the number of days drains remained in place, and the occurrence of seroma. The results would help guide surgical practice by identifying the safer and more efficient dissection method during MRM.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Mastectomy, Modified Radical Mastectomy Plus Axillary Lymph Node Dissection Seroma Following Procedure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Electrocautery Dissection Group

Axillary dissection was performed as per standard hospital protocol.

Group Type ACTIVE_COMPARATOR

Electrocautery

Intervention Type DEVICE

Axillary dissection was done through bipolar electrocautery

Ultrasonic Dissection Group

Axillary dissection was performed using ultrasonic dissector.

Group Type EXPERIMENTAL

Ultrasonic dissector

Intervention Type DEVICE

Axillary dissection was done through ultrasonic dissector.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrocautery

Axillary dissection was done through bipolar electrocautery

Intervention Type DEVICE

Ultrasonic dissector

Axillary dissection was done through ultrasonic dissector.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Bipolar electrocautery

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with breast cancer and
* Planned for modified radical mastectomy

Exclusion Criteria

* Planned with immediate reconstruction
* Women with recurrent breast cancer and
* Women with previous radiation over chest wall
Minimum Eligible Age

35 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Quaid-e-Azam Medical College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr.Maryum Naveed

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tariq I Professor, FCPS

Role: STUDY_CHAIR

Quaid-e-Azam Medical College

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Quaid-e-Azam Medical College

Bahawalpur, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

References

Explore related publications, articles, or registry entries linked to this study.

Mayer JH. Slide reproduction of radiographs: improved results with color film. AJR Am J Roentgenol. 1982 Feb;138(2):361-2. doi: 10.2214/ajr.138.2.361. No abstract available.

Reference Type BACKGROUND
PMID: 6976748 (View on PubMed)

Deori A, Gupta N, Gupta AK, Yelamanchi R, Agrawal H, Durga CK. A Prospective Randomised Controlled Study Comparing Ultrasonic Dissector with Electrocautery for Axillary Dissection in Patients of Carcinoma Breast. Malays J Med Sci. 2021 Feb;28(1):97-104. doi: 10.21315/mjms2021.28.1.12. Epub 2021 Feb 24.

Reference Type BACKGROUND
PMID: 33679225 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1324-5017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.